Practices and opinions regarding HPV vaccination among French general practitioners: evaluation through two cross-sectional studies in 2007 and 2010
- 267 Downloads
To use both quantitative and qualitative methods to investigate the evolution of practices and opinions regarding human papillomavirus (HPV) vaccination among French general practitioners.
A cross-sectional study (self-questionnaires) was performed in 2007 and repeated in 2010 among 271 general practitioners. Semi-structured interviews were conducted on 27 voluntary participants by a sociologist and analyzed according to content analysis.
Acceptability of HPV vaccination had increased from 2007 to 2010 (79.9 vs. 87.1 %, respectively), just as the practice of HPV vaccination among 14-year-old girls (19.0 vs. 49.1 %, respectively). Though about 60 % reported complications associated with HPV vaccination, irrespective of year, the types of difficulties have varied: difficulties related to “questions asked by patients” had decreased, though concerns about side effects had remained stable. During interviews, difficulties related to “the reason for medical consultation” and “the target age” were often associated with addressing the issue of sexuality, especially when the parents were present.
Although the high level of acceptability of HPV vaccination among general practitioners, which increased from 2007 to 2010, there remain difficulties in addressing this practice.
KeywordsHPV vaccination General practitioner Practice Opinion Attitude Evolution
- Creswell JW, Plano Clark VL (2007) Designing and conducting mixed methods research. Sage Publications, Thousand OaksGoogle Scholar
- Darden PM, Thompson DM, Roberts JR, Hale JJ, Pope C, Naifeh M, et al. (2013) Reasons for not vaccinating adolescents: national immunization survey of teens, 2008–2010. Pediatrics 131:645–651Google Scholar
- Dorleans F, Giambi C, Dematte L, Cotter S, Stefanoff P, Mereckiene J, et al. (2010) The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey. Euro Surv 15(47)Google Scholar
- European Centre for Disease prevention and Control (2012) ECDC guidance, introduction of HPV vaccines in European Union countries––an update. pp 19Google Scholar
- Haesebaert J, Lutringer-Magnin D, Kalecinski J, Barone G, Jacquard AC, Régnier V et al (2012) French women’s knowledge of and attitudes towards cervical cancer prevention and the acceptability of HPV vaccination among those with 14–18 year old daughters: a quantitative–qualitative study. BMC Public Health 12:1034PubMedCentralPubMedCrossRefGoogle Scholar
- Haut Conseil de la santé publique (2011). Avis relatif au vaccin Gardasil® et à la stratégie de prévention globale des cancers du col de l’utérus à la vaccination contre les infections à papillomavirus humains des jeunes filles âgées de 14 à 23 ans (HPV vaccination recommendations from the « Haut Conseil de la santé publique » in France). Available: http://www.hcsp.fr/docspdf/avisrapports/hcspa20111021_gardasil.pdf http://www.fncgm.com/images/Actualites_medicales_scientifiques/vaccin_pap_hcsp_12-2010.pdf. Accessed 22 February 2013
- Institut de Veille Sanitaire (2012) Projection de l’incidence et de la mortalité par cancer en France en 2011: col de l’utérus. Available:http://invs.sante.fr. Accessed 30 January 2013
- Kahn JA, Cooper HP, Vadaparampil ST, Pence BC, Weinberg AD, LoCoco SJ et al (2009) Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: a statewide survey of Texas physicians. Cancer Epidemiol Biomarkers Prev 18:2325–2332PubMedCrossRefGoogle Scholar
- Miles MB, Huberman MA (2003) Analyse des données qualitatives. De Boeck, Bruxelles, p 2Google Scholar